Figure 3 | Scientific Reports

Figure 3

From: A disulfidptosis-related lncRNA signature for predicting prognosis and evaluating the tumor immune microenvironment of lung adenocarcinoma

Figure 3

Construction and validation of a prognosis signature in the training set. (A,B) Further selection of prognostic DRlncRNAs was performed through LASSO regression analysis. (C) 5 DRlncRNAs were screened through the multivariate COX regression analysis. (D) A clinical correlation heatmap depicted the association between the prognostic signature of DRlncRNAs and clinical outcomes. (E) The correlation analysis for 16 DRGs and 5 DRlncRNAs used to prognostic signature construction. (F) K–M analysis for predictive capacity of DRLS. (G) The distribution of DRLS scores as well as survival status and time of each LUAD patient, along with the clustering heatmap of the 5 DRlncRNAs. (H) ROC curves for predicting the OS of 1, 3, and 5-years, along with clinical ROC curves. (I) PCA and t-SNE analyses were performed on LUAD patients based on the risk score.

Back to article page